globe usa magnifying-glass checkbox g-plus rss youtube fb-round connect-with-us-in connect-with-us-twitter youtube2 facebook linkedin twitter
The website you have requested may contain information on products or uses of such products that are not approved in your country. For specific product and country information please contact Medinol

Clinical Program

EluNIR – HBR

  • Enrollment Completed
  • TLF, ARC, MACE Primary Endponit
  • 316 Patients
  • 18 Sites UK, Israel

Prospective, Post Marketing

Single-Arm Trial

ChampioNIR – First In Human

  • Enrollment Completed
  • 30 Patients
  • 4 Sites Israel

Prospective, open label, multi-center, single arm study

EluNIR – JNIR

  • Enrollment completed
  • TLF Primary Endpoint
  • 12 M Data Reported
  • 104 Patients
  • 10 Sites Japan

Single arm study

for

regulatory approval

  • Enrollment Completed
  • 5.4% Primary Endpoint
  • 12 M Data Reported
  • 1,919 Patients
  • 76 Sites USA, Canada, Europe, Israel

More comers randomized

clinical trial

  • Enrollment Completed
  • 0.04 mm Late-loss at 6M
  • 6 M Data Reported
  • 302 Patients
  • 31 Sites Europe, Israel

More comers randomized

clinical trial